Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione
about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumA molecular marker of artemisinin-resistant Plasmodium falciparum malariaArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaGenome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasitesPlasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugsAntimalarial drug resistance: An overviewAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkThe interplay between drug resistance and fitness in malaria parasitesGlobal analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinineGenomic analysis of local variation and recent evolution in Plasmodium vivax.Structural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsAntibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infectionIdentification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparumNovel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistanceGenome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressureMitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesReal-time imaging of the intracellular glutathione redox potential in the malaria parasite Plasmodium falciparumMetabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolismA chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistryCharacterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assayWhole Genome Sequencing of Field Isolates Reveals Extensive Genetic Diversity in Plasmodium vivax from ColombiaHemozoin and antimalarial drug discoveryLocalization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membraneGlutathione transport: a new role for PfCRT in chloroquine resistanceNext-Generation Sequencing of Plasmodium vivax Patient Samples Shows Evidence of Direct Evolution in Drug-Resistance Genes.Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east MyanmarUse of magnetically purified Plasmodium falciparum parasites improves the accuracy of erythrocyte invasion assays.In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.Emerging artemisinin resistance in the border areas of Thailand.Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genesA class of tricyclic compounds blocking malaria parasite oocyst development and transmission.Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.Drug-Resistant Malaria: The Era of ACT.Discovery, mechanisms of action and combination therapy of artemisininPolymorphism of Plasmodium falciparum Na(+)/H(+) exchanger is indicative of a low in vitro quinine susceptibility in isolates from Viet Nam.Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs.Dissecting the role of glutathione biosynthesis in Plasmodium falciparum.Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reactionDegrees of chloroquine resistance in Plasmodium - is the redox system involved?
P2860
Q21032477-FA6ADF19-49F8-480C-98C1-7A6D95A29671Q22061872-FF0CBF0C-1CB6-4743-B4AB-B8FB90E673EFQ24614989-B188210E-7B97-4978-8F3D-8B1B5FE6E273Q24625172-D3550D26-44F8-496E-836E-D13F2B99F4F6Q24642214-9977E953-460C-458B-91FA-2507C4B4DB06Q26753085-B3C45193-4E7A-44E8-9EBA-92DB51E250EBQ26799713-CF9FC5AE-61A0-46AC-A952-C74AD273FE15Q26998596-7114E96B-5C5F-490D-926C-880FF74C6FEEQ27012884-8A4250EA-50DA-47FB-93DA-0B7BFC60D679Q27149930-5A556323-AD93-4806-8F1A-46D80EFF2D52Q27861940-410BC3F1-EC95-4E19-9F1C-7E9F57AB6306Q27972579-A93D0CB6-4539-4BB5-AA46-546F7D6F5289Q28473923-8D202736-1545-49BD-BD87-CC167F01350BQ28478286-9D917F7D-F935-446F-921B-146473B2D170Q28481274-5EB0152D-28B7-46B7-9A6B-14B22B1FB023Q28486079-76E1806C-B439-40D8-AFE9-174E1007F7ACQ28536670-AC488726-9E01-42C7-A6C2-E6757E747CBFQ28538247-0974BDC5-21AC-40EC-ADB0-0126FB52F9F7Q28542452-7EE77510-715D-4AF7-90C6-AF763397ADF9Q28544110-B3B104C8-31D3-489C-8A70-26665B326864Q28551791-2F845572-9D78-49D0-8417-5EADB8CAB349Q28828253-9BD52C4C-0EB6-4102-AB01-17C88F3E07F1Q30041396-CB721AED-D5D4-4143-8FEC-CCBF785D3166Q30041670-B1B92A44-686A-4471-A570-757E14220BF6Q30395320-8D15EECD-72B5-4585-B49A-E83855AFE6AEQ33910002-95DA275A-25C3-4568-8E70-FF97EE4E2675Q34130820-91BB512D-D441-47A5-B380-C8F60829F3F7Q34151002-61876FF9-05BE-436F-AEB1-767D0A50868BQ34343530-A7BB6C3F-0B54-4C9C-825F-8A749599C28DQ34359141-9C2DC55F-BE01-45A9-B296-AD81061BA735Q34467923-FB9ABA19-85D7-44B9-B818-70B4599E5C71Q34597342-9F176735-B7CA-4BF2-8FFD-17D3306D4DAFQ34681141-963A89EC-CD0D-45A5-9EFE-84A2E91CA375Q35006418-09632BCE-E82F-4B09-9EEB-E3189E7423CAQ35069374-151DE345-6E66-4E48-85CC-69394251437DQ35107675-7CFC845A-1941-4546-98DC-03BF4B3E0E74Q35149404-C18AA002-F44B-4B90-A0A3-5D1A943DD546Q35875002-935C4370-079F-4C73-B2AD-E5BC93BEE8F4Q35991544-874C0A51-1DA4-4B72-9040-D158BD554DF4Q36072626-976506E0-4124-4D99-8765-B3197FC34252
P2860
Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@ast
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@en
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@nl
type
label
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@ast
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@en
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@nl
prefLabel
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@ast
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@en
Disruption of a Plasmodium fal ...... malarial Drugs and Glutathione
@nl
P2093
P2860
P921
P3181
P356
P1476
Disruption of a Plasmodium fal ...... malarial drugs and glutathione
@en
P2093
Dipak Kumar Raj
Hongying Jiang
Jianbing Mu
Juraj Kabat
Margery Sullivan
Subash Singh
Thomas F McCutchan
P2860
P304
P3181
P356
10.1074/JBC.M806944200
P407
P577
2008-12-31T00:00:00Z